Toll-Like Receptor 3 Activation Is Required for Normal Skin Barrier Repair Following UV Damage
Andrew W. Borkowski, Richard L. Gallo(University of California San Diego), Benjamin Yu(University of California San Diego), Nai‐Jung Hung(University of California San Diego), Takeshi Yoshida(University of Rochester Medicine), Lisa A. Beck(University of Rochester Medicine), Jamie J. Bernard(Michigan Department of Health and Human Services), I‐Hsin Kuo(University of Rochester Medicine), Michael R. Williams(University of California San Diego)
Cited by 70
Related Papers
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k